Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00231907
What this trial is testing

A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 56
Post-approval studies (Phase 4)Study completedNCT01752881
What this trial is testing

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Adimmune Corporation 130
Testing effectiveness (Phase 2)Study completedNCT01651104
What this trial is testing

Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects

Who this might be right for
Human Influenza
Novartis Vaccines 63
Post-approval studies (Phase 4)Study completedNCT06987942
What this trial is testing

Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Who this might be right for
VaricellaInfluenza Vaccine
Sinovac (Dalian) Vaccine Technology Co., Ltd. 899
Early research (Phase 1)Study completedNCT01368029
What this trial is testing

Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine

Who this might be right for
HealthyElderly
Massachusetts General Hospital 28
Early research (Phase 1)Study completedNCT01164553
What this trial is testing

Comparison of Flu Vaccine Doses in Children

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 243
Early research (Phase 1)Study completedNCT00660257
What this trial is testing

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Who this might be right for
Pandemic Influenza VaccinePreventionPandemic Influenza
Sinovac Biotech Co., Ltd 57
Post-approval studies (Phase 4)Study completedNCT02655874
What this trial is testing

Tropical Influenza Control Strategies for the Elderly

Who this might be right for
Influenza, Human
Tan Tock Seng Hospital 200
Post-approval studies (Phase 4)Study completedNCT03020537
What this trial is testing

B-cell Immunity to Influenza (SLVP017)- Year 5, 2013

Who this might be right for
Influenza
Stanford University 8
Early research (Phase 1)Study completedNCT00382980
What this trial is testing

Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 308
Testing effectiveness (Phase 2)Study completedNCT00391391
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi 520
Early research (Phase 1)Study completedNCT02251288
What this trial is testing

A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine

Who this might be right for
Avian InfluenzaImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 62
Post-approval studies (Phase 4)Study completedNCT03022396
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

Who this might be right for
Influenza
Stanford University 82
Testing effectiveness (Phase 2)Study completedNCT01682369
What this trial is testing

ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

Who this might be right for
Influenza
University of Oxford 90
Large-scale testing (Phase 3)Looking for participantsNCT07211152
What this trial is testing

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 150
Large-scale testing (Phase 3)Study completedNCT03391193
What this trial is testing

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 301
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Large-scale testing (Phase 3)Study completedNCT02621177
What this trial is testing

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 385
Testing effectiveness (Phase 2)Study completedNCT00491257
What this trial is testing

The Immunogenicity and Safety of the 2007-2008 Influenza Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 130
Not applicableStudy completedNCT03743688
What this trial is testing

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaInfluenza, HumanVaccine Reaction+4 more
Vanderbilt University Medical Center 10
Next Page